Metabolic Cancer Therapy 2026: Glycolysis, Mitochondria, and the Emerging Role of GLP-1 Signaling
Cancer metabolism has become one of the most intensively studied therapeutic frontiers. While cytotoxic chemotherapy targets DNA replication, metabolic therapy targets energy production, redox balance, and biosynthesis . This article compares the mechanistic effects of: 2-Deoxy-D-glucose Metformin Berberine Ivermectin Mebendazole Fenbendazole GLP-1–based therapies such as Semaglutide and Tirzepatide We will examine how each affects: Glycolysis Mitochondrial respiration AMPK and mTOR signaling Insulin and systemic glucose flux Tumor selectivity Obesity and Cancer: Established Evidence The link between obesity and cancer is well established. The International Agency for Research on Cancer concluded in 2016 that excess body fat increases the risk of at least 13 cancers (1). Key cancers linked to obesity include: Colorectal Postmenopausal breast Endometrial Pancreatic Liver Mechanisms supported by human and translational data include: Hyperinsulinemia Chronic elevation of insulin increases...